Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 155Lymphoma 20Recurrence 17Neoplasms 12Hematologic Neoplasms 11Neoplasms, Plasma Cell 9Lymphoma, Non-Hodgkin 9Immunoglobulin Light-chain Amyloidosis 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Leukemia, Myeloid, Acute 5Hodgkin Disease 5Smoldering Multiple Myeloma 4Prostatic Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Plasma Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Breast Neoplasms 4Ovarian Neoplasms 3Melanoma 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Cytokine Release Syndrome 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroinflammatory Diseases × Plasma cell × 30 days × Clear all
NCT07614243 2026-05-29

ZFAS1-BIPN

The First Affiliated Hospital of Zhejiang Chinese Medical University

Phase NA Completed
22 enrolled
Plasma cell

Neuroinflammatory Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡